High susceptibility to fatty liver disease in two-pore channel 2-deficient mice

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Christian Grimm - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Lesca M. Holdt - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Cheng Chang Chen - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Sami Hassan - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Christoph Müller - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Simone Jörs - , Technische Universität München (Autor:in)
  • Hartmut Cuny - , Ludwig-Maximilians-Universität München (LMU), Royal Melbourne Institute of Technology University (Autor:in)
  • Sandra Kissing - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Bernd Schröder - , Institut für Physiologische Chemie, Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Elisabeth Butz - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Bernd Northoff - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Jan Castonguay - , Albert-Ludwigs-Universität Freiburg (Autor:in)
  • Christian A. Luber - , Max Planck Institute of Biochemistry, Novo Nordisk Foundation (Autor:in)
  • Markus Moser - , Max Planck Institute of Biochemistry (Autor:in)
  • Saskia Spahn - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Renate Lüllmann-Rauch - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Christina Fendel - , Universität Bonn (Autor:in)
  • Norbert Klugbauer - , Albert-Ludwigs-Universität Freiburg (Autor:in)
  • Oliver Griesbeck - , Max Planck Institute of Neurobiology (Autor:in)
  • Albert Haas - , Universität Bonn (Autor:in)
  • Matthias Mann - , Max Planck Institute of Biochemistry (Autor:in)
  • Franz Bracher - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Daniel Teupser - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Paul Saftig - , Christian-Albrechts-Universität zu Kiel (CAU) (Autor:in)
  • Martin Biel - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)
  • Christian Wahl-Schott - , Ludwig-Maximilians-Universität München (LMU) (Autor:in)

Abstract

Endolysosomal organelles play a key role in trafficking, breakdown and receptor-mediated recycling of different macromolecules such as low-density lipoprotein (LDL)-cholesterol, epithelial growth factor (EGF) or transferrin. Here we examine the role of two-pore channel (TPC) 2, an endolysosomal cation channel, in these processes. Embryonic mouse fibroblasts and hepatocytes lacking TPC2 display a profound impairment of LDL-cholesterol and EGF/EGF-receptor trafficking. Mechanistically, both defects can be attributed to a dysfunction of the endolysosomal degradation pathway most likely on the level of late endosome to lysosome fusion. Importantly, endolysosomal acidification or lysosomal enzyme function are normal in TPC2-deficient cells. TPC2-deficient mice are highly susceptible to hepatic cholesterol overload and liver damage consistent with non-alcoholic fatty liver hepatitis. These findings indicate reduced metabolic reserve of hepatic cholesterol handling. Our results suggest that TPC2 plays a crucial role in trafficking in the endolysosomal degradation pathway and, thus, is potentially involved in the homoeostatic control of many macromolecules and cell metabolites.

Details

OriginalspracheEnglisch
Aufsatznummer4699
FachzeitschriftNature communications
Jahrgang5
PublikationsstatusVeröffentlicht - 21 Aug. 2014
Peer-Review-StatusJa

Externe IDs

PubMed 25144390